CVE-2022-2735

Description

A vulnerability was found in the PCS project. This issue occurs due to incorrect permissions on a Unix socket used for internal communication between PCS daemons. A privilege escalation could happen by obtaining an authentication token for a hacluster user. With the "hacluster" token, this flaw allows an attacker to have complete control over the cluster managed by PCS.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory debian.org
Affected: n/a ClusterLabs/pcs
Published at:
Updated at:

References

Link Tags
https://bugzilla.redhat.com/show_bug.cgi?id=2116815 issue tracking third party advisory patch
https://www.openwall.com/lists/oss-security/2022/09/01/4 mailing list release notes third party advisory
https://access.redhat.com/security/cve/CVE-2022-2735 third party advisory
https://www.debian.org/security/2022/dsa-5226 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-2735?
CVE-2022-2735 has been scored as a high severity vulnerability.
How to fix CVE-2022-2735?
To fix CVE-2022-2735, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-2735 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-2735 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-2735?
CVE-2022-2735 affects n/a ClusterLabs/pcs.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.